Logo image of GNPX

GENPREX INC (GNPX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:GNPX - US3724463027 - Common Stock

1.76 USD
0 (0%)
Last: 12/30/2025, 6:42:20 PM
1.75 USD
-0.01 (-0.57%)
After Hours: 12/30/2025, 6:42:20 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GNPX. GNPX was compared to 530 industry peers in the Biotechnology industry. While GNPX seems to be doing ok healthwise, there are quite some concerns on its profitability. GNPX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GNPX had negative earnings in the past year.
In the past year GNPX has reported a negative cash flow from operations.
In the past 5 years GNPX always reported negative net income.
In the past 5 years GNPX always reported negative operating cash flow.
GNPX Yearly Net Income VS EBIT VS OCF VS FCFGNPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -518.59%, GNPX is doing worse than 96.60% of the companies in the same industry.
GNPX has a worse Return On Equity (-1320.11%) than 81.51% of its industry peers.
Industry RankSector Rank
ROA -518.59%
ROE -1320.11%
ROIC N/A
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
GNPX Yearly ROA, ROE, ROICGNPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600 -800 -1K

1.3 Margins

GNPX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GNPX Yearly Profit, Operating, Gross MarginsGNPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, GNPX has more shares outstanding
The number of shares outstanding for GNPX has been increased compared to 5 years ago.
There is no outstanding debt for GNPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GNPX Yearly Shares OutstandingGNPX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K
GNPX Yearly Total Debt VS Total AssetsGNPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -68.66, we must say that GNPX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GNPX (-68.66) is worse than 94.72% of its industry peers.
There is no outstanding debt for GNPX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -68.66
ROIC/WACCN/A
WACCN/A
GNPX Yearly LT Debt VS Equity VS FCFGNPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

GNPX has a Current Ratio of 0.83. This is a bad value and indicates that GNPX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.83, GNPX is doing worse than 89.25% of the companies in the same industry.
GNPX has a Quick Ratio of 0.83. This is a bad value and indicates that GNPX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.83, GNPX is doing worse than 88.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.83
GNPX Yearly Current Assets VS Current LiabilitesGNPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.08% over the past year.
EPS 1Y (TTM)70.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 41.33% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNPX Yearly Revenue VS EstimatesGNPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 50M 100M 150M
GNPX Yearly EPS VS EstimatesGNPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2020 2021 2022 2023 2024 2025 2026 -500 -1K -1.5K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GNPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNPX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNPX Price Earnings VS Forward Price EarningsGNPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNPX Per share dataGNPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200 -250

4.3 Compensation for Growth

GNPX's earnings are expected to grow with 41.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.33%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GNPX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

GENPREX INC

NASDAQ:GNPX (12/30/2025, 6:42:20 PM)

After market: 1.75 -0.01 (-0.57%)

1.76

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)03-30 2026-03-30/amc
Inst Owners1.3%
Inst Owner Change88.52%
Ins Owners0.08%
Ins Owner Change6.3%
Market Cap4.00M
Revenue(TTM)N/A
Net Income(TTM)-21.39M
Analysts82.86
Price TargetN/A
Short Float %8.56%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-75.79%
Min EPS beat(2)-189.09%
Max EPS beat(2)37.52%
EPS beat(4)1
Avg EPS beat(4)-55.47%
Min EPS beat(4)-189.09%
Max EPS beat(4)37.52%
EPS beat(8)2
Avg EPS beat(8)-39.29%
EPS beat(12)4
Avg EPS beat(12)-26.12%
EPS beat(16)6
Avg EPS beat(16)-17.15%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4900%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.47
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-282
EYN/A
EPS(NY)-1.17
Fwd EYN/A
FCF(TTM)-7.55
FCFYN/A
OCF(TTM)-7.55
OCFYN/A
SpS0
BVpS0.71
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -518.59%
ROE -1320.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-300.81%
ROA(5y)-201.57%
ROE(3y)-614.27%
ROE(5y)-390.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.83
Quick Ratio 0.83
Altman-Z -68.66
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)236.4%
Cap/Depr(5y)318.48%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.95%
EPS Next Y99.72%
EPS Next 2Y41.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.68%
OCF growth 3YN/A
OCF growth 5YN/A

GENPREX INC / GNPX FAQ

What is the ChartMill fundamental rating of GENPREX INC (GNPX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GNPX.


What is the valuation status of GENPREX INC (GNPX) stock?

ChartMill assigns a valuation rating of 1 / 10 to GENPREX INC (GNPX). This can be considered as Overvalued.


How profitable is GENPREX INC (GNPX) stock?

GENPREX INC (GNPX) has a profitability rating of 0 / 10.


Can you provide the financial health for GNPX stock?

The financial health rating of GENPREX INC (GNPX) is 4 / 10.